CHHAYA RAMESH PATIL
🚨 Critical Risk
FEI: 3035111324 • Mumbai, Maharashtra • INDIA
FEI Number
3035111324
Location
Mumbai, Maharashtra
Country
INDIAAddress
C - 311 Kamdhenu Societysaibaba, , Mumbai, Maharashtra, India
Critical Risk
FDA Import Risk Assessment
This firm has an extensive history of FDA import refusals with severe violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 3/10/2025 | 65KCO09MISOPROSTOL (PROSTAGLANDIN) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/10/2025 | 54FGK94ASHWAGANDHA (HERBAL & BOTANICALS, NOT TEAS) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/10/2025 | 54AGK01VITAMIN A | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/10/2025 | 65UDO03ETHANOLAMINE OLEATE (SCLEROSING AGENT) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/10/2025 | 56BDA03AMOXICILLIN TRIHYDRATE (PENICILLIN, SYNTHETICALLY PRODUCED) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/10/2025 | 61WCO04CLOTRIMAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/10/2025 | 61FCA14CEFADROXIL (ANTI-BACTERIAL) (NOT ANTIBIOTIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/10/2025 | 61FCA54CIPROFLOXACIN (ANTI-BACTERIAL PART I) (NOT ANTIBIOTIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/10/2025 | 54KGK06HOLY BASIL (HERBAL & BOTANICALS, NOT TEAS II) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/10/2025 | 54KGK06HOLY BASIL (HERBAL & BOTANICALS, NOT TEAS II) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/10/2025 | 66VCY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/10/2025 | 62GDA41IBUPROFEN (ANTI-INFLAMMATORY) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/10/2025 | 65LCO06CALAMINE (PROTECTANT) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/10/2025 | 66VCY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/10/2025 | 61TCA26ONDANSETRON (ANTI-EMETIC/NAUSEANT) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 3/10/2025 | 61WCO47KETOCONAZOLE (ANTI-FUNGAL) (NOT ANTIBIOTIC) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
Frequently Asked Questions
What is CHHAYA RAMESH PATIL's FDA import refusal history?
CHHAYA RAMESH PATIL (FEI: 3035111324) has 16 FDA import refusal record(s) in our database, spanning from 3/10/2025 to 3/10/2025.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. CHHAYA RAMESH PATIL's FEI number is 3035111324.
What types of violations has CHHAYA RAMESH PATIL received?
CHHAYA RAMESH PATIL has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about CHHAYA RAMESH PATIL come from?
All FDA import refusal data for CHHAYA RAMESH PATIL is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.